KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Supernus Pharmaceuticals (SUPN) Tax Rate (2016 - 2025)

Historic Tax Rate for Supernus Pharmaceuticals (SUPN) over the last 12 years, with Q3 2025 value amounting to 22.15%.

  • Supernus Pharmaceuticals' Tax Rate rose 78100.0% to 22.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.02%, marking a year-over-year decrease of 96200.0%. This contributed to the annual value of 24.53% for FY2024, which is 279500.0% down from last year.
  • Latest data reveals that Supernus Pharmaceuticals reported Tax Rate of 22.15% as of Q3 2025, which was up 78100.0% from 34.98% recorded in Q2 2025.
  • In the past 5 years, Supernus Pharmaceuticals' Tax Rate registered a high of 495.5% during Q3 2022, and its lowest value of 102.9% during Q1 2025.
  • For the 5-year period, Supernus Pharmaceuticals' Tax Rate averaged around 43.28%, with its median value being 24.33% (2024).
  • Its Tax Rate has fluctuated over the past 5 years, first skyrocketed by 4699500bps in 2022, then plummeted by -2475600bps in 2024.
  • Over the past 5 years, Supernus Pharmaceuticals' Tax Rate (Quarter) stood at 19.06% in 2021, then soared by 244bps to 27.49% in 2022, then crashed by -168bps to 18.69% in 2023, then soared by 323bps to 41.71% in 2024, then plummeted by -47bps to 22.15% in 2025.
  • Its Tax Rate was 22.15% in Q3 2025, compared to 34.98% in Q2 2025 and 102.9% in Q1 2025.